Kevin R Murphy, David A Beuther, Bradley Chipps, Robert A Wise, William McCann, Joan Reibman, Maureen George, Ileen Gilbert, James M Eudicone, Hitesh N Gandhi, Melissa Ross, Karin S Coyne, Robert S Zeiger
BACKGROUND: Complex models combining impairment-based control assessments with clinical characteristics and biomarkers have been developed to predict asthma exacerbations. The composite Asthma Impairment and Risk Questionnaire (AIRQ) with adjustments for demographics (age, sex, race, body mass index [BMI]) predicts 12-month exacerbation occurrence similarly to these more complex models. OBJECTIVE: To examine whether AIRQ exacerbation prediction is enhanced when models are adjusted for a wider range of clinical characteristics and biomarkers...
May 3, 2024: Journal of Allergy and Clinical Immunology in Practice